Funded Research Results

21 08, 2024

Wastewater-based surveillance of SARS-CoV-2: Short-term projection (forecasting), smoothing and outlier identification using Bayesian smoothing

Neal Evan Caminsky2024-08-26T11:34:01-04:00August 21, 2024|Funded Research Results, Wastewater Surveillance Research Group|

21 08, 2024

Combining short and long read sequencing technologies to identify SARS-CoV-2 variants in wastewater

Neal Evan Caminsky2024-08-26T15:57:55-04:00August 21, 2024|Funded Research Results, Wastewater Surveillance Research Group, Pillar 5|

30 07, 2024

SMDP: SARS-CoV-2 mutation distribution profiler for rapid estimation of mutational histories of unusual lineages

Neal Evan Caminsky2024-07-30T15:27:07-04:00July 30, 2024|Funded Research Results, Pillar 6|

13 06, 2024

Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity

Neal Evan Caminsky2024-06-13T11:49:58-04:00June 13, 2024|Funded Research Results, Pillar 1|

12 06, 2024

Dynamics of T-cell responses following COVID-19 mRNA vaccination and breakthrough infection in older adults

Neal Evan Caminsky2024-06-12T14:42:37-04:00June 12, 2024|Funded Research Results, Pillar 1|

12 06, 2024

People with Human Immunodeficiency Virus receiving suppressive antiretroviral therapy show typical antibody durability after dual coronavirus disease 2019 vaccination and strong third dose responses

Neal Evan Caminsky2024-06-12T12:21:42-04:00June 12, 2024|Funded Research Results, Pillar 1|

12 06, 2024

Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination

Neal Evan Caminsky2024-06-12T11:32:15-04:00June 12, 2024|Funded Research Results, Pillar 1|

12 06, 2024

#BeadAndThrive: How social media can support research as an iterative process

Neal Evan Caminsky2024-06-12T11:18:55-04:00June 12, 2024|Funded Research Results, Pillar 7|

12 06, 2024

Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy

Neal Evan Caminsky2024-06-13T10:23:35-04:00June 12, 2024|Funded Research Results, Pillar 1|

11 06, 2024

SARS-CoV-2 live virus neutralization after four COVID-19 doses in people with HIV receiving immunosuppressive antiretroviral therapy

Neal Evan Caminsky2024-06-11T12:21:48-04:00June 11, 2024|Funded Research Results, Pillar 1|